We are currently working on several pharmacogenomic and epilepsy predisposition projects

 

  • The development and implementation of electronic patient records to enhance the quality and efficiency of both patient care and genomics research.

  • The clinical relevance of genetic variation in vigabatrin induced visual field contriction.

  • The clinical relevance of genetic variation in weight fluctuation due to anti-convulsant medication.

  • The role of genetic variation in mesial temporal sclerosis and other 'focal' epilepsies.

  • The potential of magnetic resonance imaging to deliver novel endophenotypes to help resolve the genetic component to epilepsy.

"applying genomics to epilepsy therapeutics and predisposition"